Mrs. Short is a 62 year-old woman who finished menopause 5 years ago. At her annual physical examination this year, she was discovered to be 1.5 inches shorter than 5 years ago and tests revealed significant bone density loss. Her primary care provider has prescribed ibandronate (Boniva) 150 mg orally once a month for this problem.
What class of drug is ibandronate, and how does it work?
Mrs. Short asks whether she should take calcium supplements? What is your response? Provide a rational for your response.
What instructions should you provide to Mrs. Short for how and when to take this drug?
What drug-associated problems should you teach her to report to the prescriber?
Leave a Reply
You must be logged in to post a comment.